Hair Thinning Completed Phase 3 Trials for Dutasteride (DB01126)

Also known as: Hair Loss / Baldness / Alopecia / Bald / Alopecia NOS / Alopecias / Alopecia, unspecified

IndicationStatusPhase
DBCOND0073507 (Hair Thinning)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02014584Sexual Function in Men Receiving Dutasteride for Androgenetic AlopeciaTreatment
NCT00441116A Study To Assess The Efficacy And Safety Of Dutasteride 0.5mg Once Daily For 6 Months In The Treatment Of Male Subjects With Androgenetic AlopeciaTreatment
NCT01831791A Long-term Study to Determine Safety and Efficacy of Dutasteride in Male Subjects With Androgenetic AlopeciaTreatment